Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
03/02/2026 09:03
Feb 3 (Reuters) - NextCell Pharma AB NXTCL.ST: ANNOUNCES LONG-TERM DATA SHOWING INSULIN PRODUCTION PRESERVATION AIMS TO BRING PROTRANS AS SINGLE-INFUSION TREATMENT Source text: ID:nWkr9Kd8ZX Further company coverage: NXTCL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln